Research News

---

Topic: Diagnosis (view all topics)

Tags for topic Diagnosis:

• 1cm-1.9cm
• Ductal Carcinoma In Situ
• Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ)
• Early-stage: Stage IA
• Early-stage: Stage IB
• Early-stage: Stage IIA
• Early-stage: Stage IIB
• Early-stage: Stage IIIA
• Estrogen Receptor Negative Cancer
• Estrogen Receptor Positive Cancer
• HER2/neu Negative Cancer
• HER2/neu Positive Cancer
• HER2 Overexpressing
• Invasive or Infiltrating Ductal Carcinoma
• Invasive or Infiltrating Lobular Carcinoma
• Less than 1cm
• Locally Advanced-stage: Stage IIIB
• Locally Advanced-stage: Stage IIIC
• Luminal A
• Luminal B
• Metastatic
• Metastatic/Advanced-stage: Stage IV
• Non-Metastatic
• Progesterone Receptor Negative Cancer
• Progesterone Receptor Positive Cancer
• Regional
• Triple Negative

View articles by month and year

• Women Who Start Treatment More Than 60 Days After Diagnosis of Advanced-Stage Disease Have Worse Survival

  Published on January 31, 2013 at 4:15 am

  • Tags: Metastatic and Metastatic/Advanced-stage: Stage IV

  A study has found that women diagnosed with advanced-stage breast cancer who wait more than 60 days to start treatment have a much higher risk of dying from breast cancer than women who start treatment earlier.

• Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis

  Published on June 20, 2012 at 12:00 am

  • Tags: Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Positive Cancer, Metastatic, Non-Metastatic, Regional, Biopsy, FISH Test, IHC Test, Inform HER2 Dual ISH Test, SPoT-Light HER2 CISH, HER2/neu Negative Cancer, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  The characteristics of a breast cancer -- including hormone receptor status and HER2 status -- can change over time. These changes may happen because the cancer cells change themselves or because treat...

• Obesity Doesn’t Affect Survival in Metastatic Disease

  Published on June 10, 2011 at 12:00 am

  • Tags: Metastatic, Metastatic/Advanced-stage: Stage IV, and Obesity

  Research has found that being overweight or obese at diagnosis doesn't affect the survival of women diagnosed with metastatic breast cancer.

• Circulating Tumor Cells Linked to Worse Prognosis

  Published on December 15, 2010 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, and Blood Marker Tests

  New studies suggest that even one circulating tumor cell in a blood sample from a woman diagnosed with breast cancer is linked to a worse prognosis.

• Breast Cancer Survival Triples in Last 60 Years

  Published on September 30, 2010 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, and Metastatic/Advanced-stage: Stage IV

  During the past 60 years, the average number of women who survived for 10 years after being diagnosed with breast cancer and treated at the University of Texas MD Anderson Cancer Center tripled.

• Biopsy of Metastatic Cancer May Change Treatment Plan

  Published on June 7, 2010 at 12:00 am

  • Tags: Metastatic, Metastatic/Advanced-stage: Stage IV, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Negative Cancer, HER2/neu Positive Cancer, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Biopsy, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  Research suggests that a breast cancer's characteristics may change if the cancer metastasizes, so doing a biopsy on metastatic cancer may make sense in some cases.

• Research Finds Breast Cancer Cells Continue to Mutate

  Published on October 8, 2009 at 12:00 am

  • Tags: Metastatic and Metastatic/Advanced-stage: Stage IV

  After analyzing cells from both metastatic breast cancer and the original cancer that was diagnosed 9 years earlier, scientists found that the cancer cells continued to evolve and mutate over time.

• Metastatic Breast Cancer Often Treated with Medicines Used “Off-Label”

  Published on June 5, 2009 at 12:00 am

  • Tags: Metastatic and Metastatic/Advanced-stage: Stage IV

  "Off-label therapy," or using a medication in a way that hasn't been officially approved by the FDA, is used in one-third of women with metastatic breast cancer.

• Biopsy of Metastatic Cancer Can Improve Treatment

  Published on March 18, 2009 at 12:00 am

  • Tags: Metastatic, Metastatic/Advanced-stage: Stage IV, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Negative Cancer, HER2/neu Positive Cancer, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Biopsy, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  In some cases, certain "personality" factors of recurrent metastatic breast cancer -- hormone-receptor status and HER2 status -- can be different from the original breast cancer, which may affect treatment decisions.

• Give Us More and Better Information Say Women Diagnosed with Metastatic Disease

  Published on March 13, 2009 at 12:00 am

  • Tags: Metastatic and Metastatic/Advanced-stage: Stage IV

  Women diagnosed with metastatic breast cancer want more and better information on metastatic disease.